Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has issued an update.
Imricor Medical Systems has received its first-ever clearance from the US Food and Drug Administration for the Vision-MR Diagnostic Catheter, an MRI-guided electrophysiology device that forms a key element of its MRI-compatible EP platform. The 510(k) clearance allows Imricor to begin commercially marketing the catheter in the United States, the world’s largest electrophysiology market, marking a significant milestone in its US market entry and setting the stage for additional regulatory clearances as the company rolls out its full MRI-guided EP portfolio, with potentially meaningful implications for its growth trajectory and competitive positioning in advanced cardiac ablation technologies.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.22 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. is a medical technology company focused on making interventional procedures better, safer and more cost-effective by enabling them to be performed under real-time MRI guidance instead of traditional X-ray fluoroscopy. The company is a pioneer in MRI-compatible products for cardiac catheter ablation procedures, offering capital equipment such as the NorthStar Mapping System and Advantage-MR EP Recorder/Stimulator, along with a range of single-use ablation and diagnostic catheters, steerable sheaths and related tools, with approvals already secured in the EU, Saudi Arabia and New Zealand and further geographic expansion planned.
Average Trading Volume: 192,377
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$506.3M
For a thorough assessment of IMR stock, go to TipRanks’ Stock Analysis page.